Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 160,000 shares at $173.03 ($27.5M) on 2023-02-01, disclosed to the SEC on 2023-02-03.
Seasonal sale ($27.5M) by Chief Executive Officer — this insider has traded MRNA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $167.97 | 5,848 | $982K | 3.6% |
| 2 | $167.97 | 5,848 | $982K | 3.6% |
| 3 | $168.75 | 16,742 | $2.8M | 10.3% |
| 4 | $168.75 | 16,742 | $2.8M | 10.3% |
| 5 | $169.85 | 6,024 | $1.0M | 3.7% |
| 6 | $169.85 | 6,024 |
| $1.0M |
| 3.7% |
| 7 | $170.67 | 1,629 | $278K | 1.0% |
| 8 | $170.67 | 1,629 | $278K | 1.0% |
| 9 | $171.89 | 600 | $103K | 0.4% |
| 10 | $171.89 | 600 | $103K | 0.4% |
| 11 | $173.03 | 1,957 | $339K | 1.2% |
| 12 | $173.03 | 1,957 | $339K | 1.2% |
| 13 | $174.21 | 2,503 | $436K | 1.6% |
| 14 | $174.21 | 2,503 | $436K | 1.6% |
| 15 | $174.82 | 4,697 | $821K | 3.0% |
| 16 | $174.82 | 4,697 | $821K | 3.0% |
| 17 | $171.11 | 2,001 | $342K | 1.2% |
| 18 | $171.11 | 2,001 | $342K | 1.2% |
| 19 | $172.04 | 1,589 | $273K | 1.0% |
| 20 | $172.04 | 1,589 | $273K | 1.0% |
| 21 | $173.19 | 8,908 | $1.5M | 5.6% |
| 22 | $173.19 | 8,908 | $1.5M | 5.6% |
| 23 | $174.25 | 10,263 | $1.8M | 6.5% |
| 24 | $174.25 | 10,263 | $1.8M | 6.5% |
| 25 | $175.03 | 15,790 | $2.8M | 10.0% |
| 26 | $175.03 | 15,790 | $2.8M | 10.0% |
| 27 | $175.79 | 1,449 | $255K | 0.9% |
| 28 | $175.79 | 1,449 | $255K | 0.9% |
| Total | $172.16 avg | 160,000 | $27.5M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |